TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Smerud Medical Research International AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
104,710
|
93,818
|
66,662 |
| Financial expenses |
1,427
|
2,078
|
2,999 |
| Earnings before taxes |
10,077
|
19,900
|
6,144 |
| Total assets |
46,167
|
39,649
|
50,181 |
| Current assets |
42,160
|
35,414
|
45,497 |
| Current liabilities |
20,519
|
22,019
|
36,630 |
| Equity capital |
25,648
|
17,630
|
13,551 |
| - share capital |
107
|
109
|
116 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
55.6%
|
44.5%
|
27.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
9.6%
|
21.2%
|
9.2% |
| Return on assets (ROA) |
24.9%
|
55.4%
|
18.2% |
| Current ratio |
205.5%
|
160.8%
|
124.2% |
| Return on equity (ROE) |
39.3%
|
112.9%
|
45.3% |
| Change turnover |
12,553
|
31,574
|
30,118 |
| Change turnover % |
14%
|
51%
|
82% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.